Gestational diabetes & diabetes in pregnancy

Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Early Pregnancy: The MOMPOD Randomized Clinical Trial

JAMAPublished Randomised controlled trial

Primary result · Composite adverse neonatal outcomeResult — go to the resultAdjusted odds ratio 0.86 95% CI 0.63–1.19
  • halted at 75% accrual for futility
  • Study halted at 75% accrual for futility

Authors' conclusion

Using metformin plus insulin to treat preexisting type 2 or gestational diabetes diagnosed early in pregnancy did not reduce a composite neonatal adverse outcome. The effect of reduction in odds of a large-for-gestational-age infant observed after adding metformin to insulin warrants further investigation.

Study context

Population
Pregnant adults aged 18 to 45 years with preexisting T2D or diabetes diagnosed prior to 23 weeks' gestation, 17 US centers, 2019–2021794 analysed
Participants
831 adults
Comparison
Metformin vs placebo added to insulin
  • Metforminn = 397
  • Placebon = 397reference
Primary endpoint
Composite of:
  • Neonatal complications including perinatal death
  • Preterm birth
  • Large or small for gestational age
  • Hyperbilirubinemia requiring phototherapy
Methodological detailsplacebo-controlled, multicentre (17 US centers)
  • Placebo-controlled
  • Multicentre (17 US centers)

Primary result

Composite adverse neonatal outcome

Adjusted odds ratio

0.86

95% CI 0.63–1.19

Events by treatment group

Metforminvs Placebo
aOR 0.86 (95% CI 0.63–1.19)

As reported in the abstract

Secondary outcomes

OutcomeaOR (95% CI)
Large for gestational age (component of primary composite)0.63 (0.46–0.86)

Prespecified secondary outcomes (incl. maternal hypoglycemia, neonatal fat mass) and subgroup analyses

Similar between groups

Original publication

Metformin Plus Insulin for Preexisting Diabetes or Gestational Diabetes in Early Pregnancy: The MOMPOD Randomized Clinical Trial. JAMA. Published 12 December 2023. doi:10.1001/jama.2023.22949

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.